985 EFFICACY OF MIRIKIZUMAB IN COMPARISON TO USTEKINUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: RESULTS FROM THE PHASE 3 VIVID 1 STUDY

The requested reference [d154890cd9bf906856d548ffd472a5fbb6559730] no longer exists in our database. It has been replaced by the current reference: [389e7887e47a2fd0ff215abe09cc2195b198ca4b]

Authors
Category Primary study
ConferenceGastroenterology
Year 2024
This article has no abstract
Epistemonikos ID: 0020bb47a09fc04201c6ce6c0fb0ddfd07974baa
First added on: Apr 29, 2026